More than a dozen leaders in the field will speak on topics ranging from pluripotent stem cells for the treatment of severe heart failure to 3-D printing of extracellular matrices.
May 1, 2015
Joseph Wu
The Stanford Cardiovascular Institute is holding its second annual Cardiovascular Tissue Engineering Symposium from 9 a.m. to 4:30 p.m. May 22 at the Clark Center.
The symposium, which is free and open to the public, will focus on new approaches to repair damaged portions of the heart and vasculature. More than a dozen leaders in the field will speak on topics ranging from pluripotent stem cells for the treatment of severe heart failure to 3-D printing of extracellular matrices.
“Significant advances in our understanding of how to coax stem cells toward a cardiovascular cell fate has made it possible to now consider whether these cells are ready for human testing,” said Joseph Wu, MD, PhD, director of the institute and professor of medicine and of radiology. “Combined with advances in imaging, biomaterials and stem cells, it’s exciting to see new ideas and applications becoming a clinical reality.”
Many of the invited speakers are involved in clinical trials, and several have founded their own biotechnology companies based on their innovations.
For more information or to register, visit http://cvi.stanford.edu/mission/cardiac-engineering-symposium.html.
About Stanford Medicine
Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.
